Found: 39
Select item for more details and to access through your institution.
The Synthetic Curcumin Analog HO-3867 Rescues Suppression of PLAC1 Expression in Ovarian Cancer Cells.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Investigating the effect of optimal cytoreduction in the context of platinum sensitivity in high‐grade serous ovarian cancer.
- Published in:
- Acta Obstetricia et Gynecologica Scandinavica, 2022, v. 101, n. 10, p. 1085, doi. 10.1111/aogs.14415
- By:
- Publication type:
- Article
Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 16014, doi. 10.3390/ijms232416014
- By:
- Publication type:
- Article
Using Genomic Variation to Distinguish Ovarian High-Grade Serous Carcinoma from Benign Fallopian Tubes.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14814, doi. 10.3390/ijms232314814
- By:
- Publication type:
- Article
Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4791, doi. 10.3390/ijms22094791
- By:
- Publication type:
- Article
Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1079, doi. 10.3390/ijms22031079
- By:
- Publication type:
- Article
A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 5, p. 1205, doi. 10.3390/ijms20051205
- By:
- Publication type:
- Article
Population Substructure Has Implications in Validating Next-Generation Cancer Genomics Studies with TCGA.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 5, p. 1192, doi. 10.3390/ijms20051192
- By:
- Publication type:
- Article
Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 5, p. 1175, doi. 10.3390/ijms20051175
- By:
- Publication type:
- Article
Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profile.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1105504
- By:
- Publication type:
- Article
Identification of a new prostate cancer susceptibility locus on chromosome 8q24.
- Published in:
- Nature Genetics, 2009, v. 41, n. 10, p. 1055, doi. 10.1038/ng.444
- By:
- Publication type:
- Article
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).
- Published in:
- Nature Genetics, 2009, v. 41, n. 5, p. 579, doi. 10.1038/ng.353
- By:
- Publication type:
- Article
Multiple loci identified in a genome-wide association study of prostate cancer.
- Published in:
- Nature Genetics, 2008, v. 40, n. 3, p. 310, doi. 10.1038/ng.91
- By:
- Publication type:
- Article
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-129
- By:
- Publication type:
- Article
Detection of Somatic Mutations by High-Resolution DNA Melting (HRM) Analysis in Multiple Cancers.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0014522
- By:
- Publication type:
- Article
Prediction of chemo-response in serous ovarian cancer.
- Published in:
- Molecular Cancer, 2016, v. 15, p. 1, doi. 10.1186/s12943-016-0548-9
- By:
- Publication type:
- Article
Fine mapping of 14q24.1 breast cancer susceptibility locus.
- Published in:
- Human Genetics, 2012, v. 131, n. 3, p. 479, doi. 10.1007/s00439-011-1088-4
- By:
- Publication type:
- Article
Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer.
- Published in:
- Human Genetics, 2009, v. 126, n. 6, p. 743, doi. 10.1007/s00439-009-0723-9
- By:
- Publication type:
- Article
Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3316, doi. 10.3390/cancers15133316
- By:
- Publication type:
- Article
Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143554
- By:
- Publication type:
- Article
Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1109, doi. 10.3390/cancers13051109
- By:
- Publication type:
- Article
Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options.
- Published in:
- PLoS ONE, 2021, v. 16, n. 1, p. 1, doi. 10.1371/journal.pone.0245664
- By:
- Publication type:
- Article
Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54401-w
- By:
- Publication type:
- Article
FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 5, p. 1, doi. 10.1002/ctm2.1223
- By:
- Publication type:
- Article
Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.
- Published in:
- Carcinogenesis, 2010, v. 31, n. 5, p. 827, doi. 10.1093/carcin/bgp328
- By:
- Publication type:
- Article
Genome-wide association studies in cancer—current and future directions.
- Published in:
- Carcinogenesis, 2010, v. 31, n. 1, p. 111, doi. 10.1093/carcin/bgp273
- By:
- Publication type:
- Article
BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin.
- Published in:
- Journal of Gynecologic Oncology, 2012, v. 23, n. 1, p. 35, doi. 10.3802/jgo.2012.23.1.35
- By:
- Publication type:
- Article
Genomic characterization of five commonly used endometrial cancer cell lines.
- Published in:
- International Journal of Oncology, 2020, v. 57, n. 6, p. 1348, doi. 10.3892/ijo.2020.5139
- By:
- Publication type:
- Article
p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers.
- Published in:
- International Journal of Oncology, 2017, v. 50, n. 5, p. 1721, doi. 10.3892/ijo.2017.3931
- By:
- Publication type:
- Article
Creation and validation of models to predict response to primary treatment in serous ovarian cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85256-9
- By:
- Publication type:
- Article
Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer.
- Published in:
- Human Molecular Genetics, 2011, v. 20, n. 14, p. 2869, doi. 10.1093/hmg/ddr189
- By:
- Publication type:
- Article
Differentially expressed genes in preimplantation human embryos: potential candidate genes for blastocyst formation and implantation.
- Published in:
- Journal of Assisted Reproduction & Genetics, 2016, v. 33, n. 8, p. 1017, doi. 10.1007/s10815-016-0745-x
- By:
- Publication type:
- Article
An integrated prediction model of recurrence in endometrial endometrioid cancers.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 5301, doi. 10.2147/CMAR.S202628
- By:
- Publication type:
- Article
Identifying novel ovarian tumor biomarkers through mining of the transcriptome of circulating immune cells: A proof‐of‐concept study.
- Published in:
- American Journal of Reproductive Immunology, 2021, v. 86, n. 4, p. 1, doi. 10.1111/aji.13469
- By:
- Publication type:
- Article
ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0278408
- By:
- Publication type:
- Article
A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo-response in high-grade serous ovarian cancer.
- Published in:
- Oncology Letters, 2021, v. 22, n. 4, p. N.PAG, doi. 10.3892/ol.2021.12994
- By:
- Publication type:
- Article
Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.
- Published in:
- Oncology Letters, 2016, v. 11, n. 1, p. 323, doi. 10.3892/ol.2015.3883
- By:
- Publication type:
- Article
The miR-503 cluster is coordinately under-expressed in endometrial endometrioid adenocarcinoma and targets many oncogenes, cell cycle genes, DNA repair genes and chemotherapy response genes.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 7205, doi. 10.2147/OTT.S180921
- By:
- Publication type:
- Article
Role of metadherin in estrogen-regulated gene expression.
- Published in:
- International Journal of Molecular Medicine, 2017, v. 40, n. 2, p. 303, doi. 10.3892/ijmm.2017.3020
- By:
- Publication type:
- Article